Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2026-09-21 16:24:49 ET · period of report 2026-09-18 · accession 0001470831-26-000895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 16:24 | 2026-09-18 | CCCC | Adams Kendra | CFO | M - OptEx | $0.00 | +6,250 | 385.1K | +2% | $0 | |
| 2026-09-21 16:24 | 2026-09-18 | CCCC | Adams Kendra | CFO | F - Tax | $3.39 | -2,775 | 382.3K | -0.7% | -$9,407 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-18 | M | A | 6,250 | $0.00 | 385,098 | D | — | — | (F1) Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023. |
| 2 | Common | Common Stock | 2026-09-18 | F | D | 2,775 | $3.39 | 382,323 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. |